Zyprexa Podcasts This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Effect of Maintenance Olanzapine vs Placebo on Psychotic Depression Relapse, Abnormal TFTs and Preterm Birth, USPSTF BRCA Testing Guidelines, and more
August 20, 2019 edition of the weekly JAMA Editors' Summary (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - August 20, 2019 Category: General Medicine Authors: JAMA Network Source Type: podcasts

FDA Drug Safety Podcast: FDA warns about rare but serious skin reactions with mental health drug olanzapine (Zyprexa, Zyprexa Zydis, Zyprexa Relprevv, and Symbyax)
(Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - February 9, 2019 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts

Olanzapine for nausea control in chemotherapy-treated patients
Charles Loprinzi, MD of Mayo Clinic, Rochester, MN discusses the use of olanzapine for nausea control in chemotherapy-treated patients. Data show that olanzapine, an antipsychotic medication, can redu... Author: VJOncology Added: 08/31/2016 (Source: Oncology Tube)
Source: Oncology Tube - August 31, 2016 Category: Cancer & Oncology Source Type: podcasts

FDA Drug Safety Podcast: FDA warns about rare but serious skin reactions with mental health drug olanzapine (Zyprexa, Zyprexa Zydis, Zyprexa Relprevv, and Symbyax)
On May 10, 2016, the U.S. Food and Drug Administration (FDA) announced it is warning that the antipsychotic medicine olanzapine can cause a rare but serious skin reaction that can progress to affect other parts of the body. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - May 17, 2016 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts

Olanzapine Decreases Nausea and Vomiting in Patients With Esophageal, Head and Neck Cancer
Charles L. Loprinzi, MD, of the Mayo Clinic reviews how Olanzapine Decreases Nausea and Vomiting in Patients With Esophageal, Head and Neck Cancer Author: cancergiants Added: 06/18/2015 (Source: Oncology Tube)
Source: Oncology Tube - June 18, 2015 Category: Cancer & Oncology Source Type: podcasts